Literature DB >> 18704404

MicroPET imaging of 5-HT 1A receptors in rat brain: a test-retest [18F]MPPF study.

Nicolas Aznavour1, Chawki Benkelfat, Paul Gravel, Antonio Aliaga, Pedro Rosa-Neto, Barry Bedell, Luc Zimmer, Laurent Descarries.   

Abstract

PURPOSE: Earlier studies have shown that positron emission tomography (PET) imaging with the radioligand [(18)F]MPPF allows for measuring the binding potential of serotonin 5-hydroxytryptamine(1A) (5-HT(1A)) receptors in different regions of animal and human brain, including that of 5-HT(1A) autoreceptors in the raphe nuclei. In the present study, we sought to determine if such data could be obtained in rat, with a microPET (R4, Concorde Microsystems).
METHODS: Scans from isoflurane-anaesthetised rats (n = 18, including six test-retest) were co-registered with magnetic resonance imaging data, and binding potential, blood to plasma ratio and radiotracer efflux were estimated according to a simplified reference tissue model.
RESULTS: Values of binding potential for hippocampus (1.2), entorhinal cortex (1.1), septum (1.1), medial prefrontal cortex (1.0), amygdala (0.8), raphe nuclei (0.6), paraventricular hypothalamic nucleus (0.5) and raphe obscurus (0.5) were comparable to those previously measured with PET in cats, non-human primates or humans. Test-retest variability was in the order of 10% in the larger brain regions (hippocampus, medial prefrontal and entorhinal cortex) and less than 20% in small nuclei such as the septum and the paraventricular hypothalamic, basolateral amygdaloid and raphe nuclei.
CONCLUSIONS: MicroPET brain imaging of 5-HT(1A) receptors with [(18)F]MPPF thus represents a promising avenue for investigating 5-HT(1A) receptor function in rat.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18704404     DOI: 10.1007/s00259-008-0891-1

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  57 in total

Review 1.  Autoregulation of serotonin neurons: role in antidepressant drug action.

Authors:  G Piñeyro; P Blier
Journal:  Pharmacol Rev       Date:  1999-09       Impact factor: 25.468

Review 2.  The medical benefit of 5-HT research.

Authors:  Brian J Jones; Thomas P Blackburn
Journal:  Pharmacol Biochem Behav       Date:  2002-04       Impact factor: 3.533

3.  Effect of a P-glycoprotein inhibitor, Cyclosporin A, on the disposition in rodent brain and blood of the 5-HT1A receptor radioligand, [11C](R)-(-)-RWAY.

Authors:  Jeih-San Liow; Shuiyu Lu; Julie A McCarron; Jinsoo Hong; John L Musachio; Victor W Pike; Robert B Innis; Sami S Zoghbi
Journal:  Synapse       Date:  2007-02       Impact factor: 2.562

4.  Differential effects of paroxetine on raphe and cortical 5-HT1A binding: a PET study in monkeys.

Authors:  Giampiero Giovacchini; Lixin Lang; Ying Ma; Peter Herscovitch; William C Eckelman; Richard E Carson
Journal:  Neuroimage       Date:  2005-07-01       Impact factor: 6.556

5.  A PET imaging study of 5-HT(1A) receptors in cat brain after acute and chronic fluoxetine treatment.

Authors:  Nicolas Aznavour; Latifa Rbah; Mustapha Riad; Anthonin Reilhac; Nicolas Costes; Laurent Descarries; Luc Zimmer
Journal:  Neuroimage       Date:  2006-09-25       Impact factor: 6.556

6.  Test-retest reproducibility of 18F-MPPF PET in healthy humans: a reliability study.

Authors:  Nicolas Costes; Luc Zimmer; Anthonin Reilhac; Franck Lavenne; Philippe Ryvlin; Didier Le Bars
Journal:  J Nucl Med       Date:  2007-07-13       Impact factor: 10.057

7.  P-[18F]-MPPF: a potential radioligand for PET studies of 5-HT1A receptors in humans.

Authors:  C Y Shiue; G G Shiue; P D Mozley; M P Kung; Z P Zhuang; H J Kim; H F Kung
Journal:  Synapse       Date:  1997-02       Impact factor: 2.562

Review 8.  Visualisation of serotonin-1A (5-HT1A) receptors in the central nervous system.

Authors:  J Passchier; A van Waarde
Journal:  Eur J Nucl Med       Date:  2001-01

9.  [11C]-DASB, a tool for in vivo measurement of SSRI-induced occupancy of the serotonin transporter: PET characterization and evaluation in cats.

Authors:  Nathalie Ginovart; Alan A Wilson; Jeffrey H Meyer; Doug Hussey; Sylvain Houle
Journal:  Synapse       Date:  2003-02       Impact factor: 2.562

10.  Modeling [18 F]MPPF positron emission tomography kinetics for the determination of 5-hydroxytryptamine(1A) receptor concentration with multiinjection.

Authors:  Nicolas Costes; Isabelle Merlet; Luc Zimmer; Franck Lavenne; Luc Cinotti; Jacques Delforge; André Luxen; Jean-François Pujol; Didier Le Bars
Journal:  J Cereb Blood Flow Metab       Date:  2002-06       Impact factor: 6.200

View more
  5 in total

1.  Serotonin Signaling through Prefrontal Cortex 5-HT1A Receptors during Adolescence Can Determine Baseline Mood-Related Behaviors.

Authors:  Alvaro L Garcia-Garcia; Qingyuan Meng; Sarah Canetta; Alain M Gardier; Bruno P Guiard; Christoph Kellendonk; Alex Dranovsky; E David Leonardo
Journal:  Cell Rep       Date:  2017-01-31       Impact factor: 9.423

Review 2.  Quantitative Rodent Brain Receptor Imaging.

Authors:  Kristina Herfert; Julia G Mannheim; Laura Kuebler; Sabina Marciano; Mario Amend; Christoph Parl; Hanna Napieczynska; Florian M Maier; Salvador Castaneda Vega; Bernd J Pichler
Journal:  Mol Imaging Biol       Date:  2020-04       Impact factor: 3.488

3.  The neurobiology of depression--revisiting the serotonin hypothesis. II. Genetic, epigenetic and clinical studies.

Authors:  Paul R Albert; Chawki Benkelfat
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-02-25       Impact factor: 6.237

4.  Reproducibility of non-invasive a1 adenosine receptor quantification in the rat brain using [(18)F]CPFPX and positron emission tomography.

Authors:  Tina Kroll; David Elmenhorst; Angela Weisshaupt; Simone Beer; Andreas Bauer
Journal:  Mol Imaging Biol       Date:  2014-10       Impact factor: 3.488

Review 5.  G protein-coupled receptors in the hypothalamic paraventricular and supraoptic nuclei--serpentine gateways to neuroendocrine homeostasis.

Authors:  Georgina G J Hazell; Charles C Hindmarch; George R Pope; James A Roper; Stafford L Lightman; David Murphy; Anne-Marie O'Carroll; Stephen J Lolait
Journal:  Front Neuroendocrinol       Date:  2011-07-23       Impact factor: 8.606

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.